Top section
Top section
Placement 3.7 times subscribed, weeks after regulator halted unauthorised marketing of a purported public offer
Markus Meier and Thore Zimmermann promoted
IPO pipeline strong, but timetables slipping as markets await clarity on tax, growth and defence funding
More articles
More articles
More articles
-
EMC, the Russian private healthcare company, has unveiled the price range for its IPO on the Moscow Exchange. -
Octopus Renewables Investment Trust, the London-listed fund focused on renewable energy assets, has completed its latest share sale, raising £150m.
-
Chinese biotechnology company Brii Biosciences has raised HK$2.48bn ($319.7m) from its Hong Kong IPO, after pricing the deal at the top of the marketed range.
-
Philippines-based real estate developer Filinvest Land has won IPO approval for a real estate investment trust (Reit), as the asset class grows in popularity in the country.
-
China's latest crackdown of three of its technology companies has a clear message for firms looking to list in the US — and investors wanting to buy their shares.
-
Rothschild & Co has hired Timothy Lufkin as a managing director covering financial sponsors within its global advisory business in New York. Lufkin previously worked at Truist and its predecessor, BB&T Capital Markets.
Sub-sections
shared comment list
